Skip to main content

Table 1 Clinical and demographic characteristics of 72 patients who underwent curative gastric resection or gastrectomy

From: Original article: role of adjuvant chemotherapy in a perioperative chemotherapy regimen for gastric cancer

Characteristic

 

Patients total

n = 72

No.

%

Gender

Male

48

66.7

Female

24

33.3

Age [y]

Median

61.51

Range

30.63 – 83.24

BMI n = 62

Median

25.2

 

Range

16.0 – 37.1

ASA n = 71

 

I

5

7.0

 

II

42

59.2

 

III

24

33.8

Medication

 Cortisone

yes

0

0.0

no

72

100.0

 Immunsup.

yes

2

2.8

no

70

97.2

 HTN

yes

32

44.4

no

40

55.6

Comorbidities

 DM

no

65

90.3

NIDDM

7

9.7

IDDM

0

0.0

 CHD

yes

7

9.7

no

65

90.3

 Cirrhosis

yes

0

0.0

no

72

100.0

 COPD

yes

0

0.0

no

72

100.0

Primary tumor location

 AEG II

 

22

30.6

 AEG III

 

8

11.1

 Corpus

 

24

33.3

 Pylorus

 

17

23.6

 unknown

 

1

1.4

ypUICC-Stage

 0

 

8

11.1

 I

 

25

34.7

 II

 

16

22.2

 III

 

23

31.9

ypT-Stage

 0

 

9

12.5

 1

 

13

18.1

 2

 

19

26.4

 3

 

25

34.7

 4

 

6

8.3

ypN-Stage

 0

 

44

61.1

 1

 

20

27.8

 2

 

5

6.9

 3

 

3

4.2

ypM-Stage

 0

 

70

97.2

 x

 

2

2.8

  1. BMI body mass index, ASA American Society of Anesthesiologists score, Immunsup immune suppressing medication, HTN blood pressure medication, DM diabetes mellitus, NIDDM non-insulin depended DM, IDDM insulin depended DM, CHD coronary heart disease, COPD chronic obstructive pulmonary disease, AEG adenocarcinoma of the esophageal gastric junction, UICC union internationale contre le cancer